Evidera is evolving

ISPOR 2025

  • May 13 - May 16, 2025
  • Montreal, Canada
  • Booth #1201

See the Real-World Evolution at ISPOR

Ready for the most comprehensive, connected, customizable set of real-world data and evidence, health economics and market access, and patient-centered research solutions? Our multi-disciplinary team is purpose-built to provide integrated solutions across the product development and commercialization life cycle. Our deep expertise and connected disciplines simplify your complex research needs, providing seamless support from initial development to market access.

Visit us at Booth # 1201 or schedule a meeting on-site to discuss our customized offerings.

Evidera is evolving. Learn more.

    Our Solutions

    Do you understand the complex nuances of the US IRA?

    Learn more

    Are you ready to navigate the EU HTA Regulation?

    Learn more

    Which patient engagement strategies will optimize your clinical study?

    Learn more

    insert image

    Can our real-world data and evidence solutions fast-track approval and secure market access for your asset?

    Learn more

    Educational Symposium

    Wednesday, May 14 • 11:45am – 12:45pm

    Navigating the Path to COA Label Claims: Overcoming Challenges and Seizing Opportunities – A Success Story in Tenosynovial Giant Cell Tumor

    Speakers: Heather Gelhorn, Katelyn N Cutts

      Issue Panel

      Thursday, May 15 • 5:00pm – 6:00pm

      How Should Artificial Intelligence (Not) Be Used in Health Preference Research?

      Speaker: Sebastian Heidenreich

        Workshop

        Thursday, May 15 • 1:45pm – 2:45pm

        Best Research Practice: Does the Practice of Implementation Sciences Have a Place in Industry-Sponsored Research?

        Speaker: Bridget Gaglio

          Breakout Sessions

          Wednesday, May 14 • 10:15am – 11:15am

          From General to HEOR-Specific: Transforming LLMs Into Reliable Research Tools

          Speaker: Apoorva Ambavane

          Moderator: J. Jaime Caro

          Friday, May 16 • 8:00am – 9:00am

          Alternative Recruitment Options for Patient Preference Studies: Thinking Outside the Market Research Panel Box

          Speaker: Sebastian Heidenreich

          Research Podiums

          Thursday, May 15 • 5:00pm – 6:00pm

          Transportability of Treatment Effect Measures in Population-Adjusted Indirect Comparisons

          Session Title: Frontiers in Survival Analysis for Health Technology Assessment

          Authors: Conor Chandler, K. Jack Ishak

          Thursday, May 15 • 5:00pm – 6:00pm

          Probabilistic Attribute Presentation in Discrete Choice Experiments: A Review of Current Practice

          Session Title: Current Trends and Advances in Health Preference Methods and Insights from Health Preference Studies

          Authors: Gabriela Fernandez, Matt Quaife

          Poster Presentations





          Wednesday, May 14

          Session 1

          The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review

          C Casañas i Comabella, S Punja

          Assessing the Feasibility of Indirect Comparisons of Vaccines: A Framework for Network Meta-Analysis

          A Cichewicz, M Betts, H Burnett

          Other Similar Measures? – How Different Really Are QALYs From Life Years, Health Years in Total, and Equal Value Life Years?

          A Ambavane, S Mahajan, J Caro

          An Artificial Intelligence (AI)-Assisted Systematic Literature Review (SLR) of the Economic Burden in Metastatic Pancreatic Adenocarcinoma: A Proof-of-Concept Study

          C Casañas i Comabella, A Cichewicz

          Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Vaccination Booster in Dominican Republic

          E Aruffo, B Yarnoff

          Current Evidence and Research Gaps on the Economic Burden of Graves’ Disease: A Targeted Literature Review

          E Mandal, S Ronnebaum, S Norregaard

          Leveraging Real-World Data Versus External Trial to Inform Comparative Efficacy within Single-Arm Trial-Based NICE Submissions

          S Wu, E Zhang, D Zou

          Wednesday, May 14

          Session 2

          Use of Artificial Intelligence for Rapid Epidemiology Reviews With Pooled Prevalence and Incidence Estimates

          A Cichewicz, K Schaible

          Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature

          C Michaels-Igbokwe, H Lu, A Doldos, H Gelhorn

          Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Vaccination Booster in Costa Rica

          E Aruffo, B Yarnoff

          Thursday, May 15

          Session 3

          Diagnosis and Treatment Journey of Patients With Atrial Fibrillation Prior to Stroke Occurrence

          D Lambrelli, A Wolf

          Exploring Treatment Preferences for Rare Diseases: A Systematic Review of Quantitative Preference Studies

          C Michaels-Igbokwe, M Venkatraman, K Meginnis

          Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China

          B Lu

          Thursday, May 15

          Session 4

          Stability of a Large Language Model for Data Extraction in Systematic Literature Reviews

          A Shree, M Farraia, C Casañas i Comabella, A Cichewicz

          Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients with Alpha-1 Antitrypsin Deficiency

          K Cutts, T Fikre, Yipin Han, Heather Gelhorn

          Post-DCE Qualitative Interviews: A Novel Method to Understand the Rationale for Stated Preferences – An Example Among Patients and Physicians in Severe Asthma

          H Gelhorn, H Collacott, M Ross

          Healthcare Burden Among Patients with Graves’ Disease: A Targeted Literature Review

          E Mandal, S Ronnebaum, S Norregaard

          Friday, May 16

          Session 5

          Humanistic Burden in mTNBC: A Systematic Literature Review

          I Puskulka, M Betts, S Egodage, H Ogden

          Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial

          H Gelhorn; K Cutts, T Fikre; Y Han

          Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population

          S Mulnick, M Ross, A Samuelson

          Mind The Gap: Delays Between Vaccine Licensure And NITAG Recommendation In The US Versus Europe

          S James, R Chapman, K Schaible, A D’Ausilio

          Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Vaccination Booster in Guatemala

          E Aruffo, B Yarnoff

          Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods

          K Jack Ishak, C Chandler, I Proskorovsky, Kyle F, V Kapetanakis

              Share this...